Oncotelic Therapeutics, Inc. (OTLC) › RevenueOncotelic Therapeutics, Inc. (OTLC) — RevenueAnnual figures by fiscal year, from SEC filings.2020: $1.74M2023: $70.0K$70.0K2020Revenue (USD)2023Fiscal YearRevenueChange YoY2023$70.0K—2020$1.74M—Other metrics: Cost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share